Finorify

PTCT

Ptc Therapeutics

$78.48-0.46%

Price

PTCT daily closing price
Market cap
$6.51 billion
P/E (TTM)
224
EV/EBITDA
25.90
Volume
572.7K
Sector
Healthcare

Ptc Therapeutics (PTCT) last closed at $78.48, on a daily price path from October 21, 2025 to October 21, 2026. Overview is that price path. Performance is the change in the close over the periods Finorify shows on the stock screen. Financials, cash flow, and margins come from reported quarters. Valuation lists the latest ratios. This snapshot is the Finorify stock screen for PTCT, covered for search and blurred for visitors.

Performance

  • 1D-0.48%
  • 5D+4.94%
  • 1M-5.06%
  • 3M-20.18%
  • 6M-11.62%
  • 1Y-8.40%
  • 5Y+68.42%

Financials

PTCT revenueQ1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26Q2 '26

Over the latest four reported periods ending June 30, 2026, Ptc Therapeutics reported revenue of $1.02 billion.

The prior window totaled $1.77 billion, so the latest window is lower than that stretch.

Operating cash flow in the latest window was -$54.6 million.

Free cash flow in the latest window was -$62.7 million.

These amounts are taken from Ptc Therapeutics's SEC filings and are a snapshot as of August 14, 2026. They are not a live price, and they are not a recommendation to buy or sell. Finorify uses the same filings to draw the charts inside the app.

A few ratios from those statements: Profitability: ROE -50.5% (0 of 100). Cash generation: FCF margin -6.1% (0 of 100). Net margin: 23.2% (58 of 100). Liquidity: Current 3.39× (100 of 100).

Cash Flow

PTCT free cash flowQ1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26Q2 '26

Margins

PTCT operating margin

Valuation

P/E (TTM)
224
P/S (TTM)
6.39
EV/EBITDA
25.90

Insights

Finorify has not written notes for PTCT in this snapshot.

Read the live analysis in Finorify

Charts, news, and the written notes are in the app. You can open five distinct stocks free. After that, the stock screen is a Finorify Pro feature.

Open PTCT in Finorify